Leandro holds a PhD in Biostatistics from Hasselt University in collaboration with IDDI and is a member of the International Society for Clinical Biostatistics and the Belgian Statistical Society. He joined IDDI in 2019 and now leads statistical research on surrogate endpoints, interim analyses using early endpoints, and Bayesian trial methodology.

He advises biotech and pharmaceutical teams on clinical trial study design and statistical modeling across oncology, ophthalmology, and Alzheimer’s disease. His expertise includes diagnostic trials, Bayesian methodology, and endpoint strategy to support early-phase decisions and reduce uncertainty in trial planning.

Leandro has designed statistical strategies for dozens of clinical trials from phase I to IV, helping teams align methodology with regulatory expectations, improve analysis interpretability, and minimize the risk of protocol amendments.

Research Gate Profile

Back to Team